Johnson–Munson syndrome
| Johnson–Munson syndrome | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Genetics, Neurology |
| Symptoms | Muscle weakness, Ataxia, Seizures, Developmental delay |
| Complications | N/A |
| Onset | Infancy |
| Duration | Chronic |
| Types | |
| Causes | Genetic mutation |
| Risks | |
| Diagnosis | Genetic testing, Clinical evaluation |
| Differential diagnosis | Cerebral palsy, Muscular dystrophy |
| Prevention | |
| Treatment | Supportive care, Physical therapy, Anticonvulsants |
| Medication | |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | |
Johnson–Munson syndrome is a rare genetic disorder characterized by intellectual disability, microcephaly, short stature, and distinctive facial features. The syndrome was first described by Johnson and Munson in 1989.
Etymology[edit]
The syndrome is named after the two doctors, Johnson and Munson, who first described the condition in 1989.
Symptoms and Signs[edit]
The main symptoms of Johnson–Munson syndrome include:
- Intellectual disability
- Microcephaly (small head size)
- Short stature
- Distinctive facial features such as a broad forehead, deep-set eyes, and a small chin
Causes[edit]
Johnson–Munson syndrome is a genetic disorder. It is caused by mutations in a specific gene, although the exact gene is not yet known.
Diagnosis[edit]
Diagnosis of Johnson–Munson syndrome is based on the presence of the characteristic symptoms and signs. Genetic testing may also be used to confirm the diagnosis.
Treatment[edit]
There is currently no cure for Johnson–Munson syndrome. Treatment is focused on managing the symptoms and improving the quality of life for individuals with the syndrome. This may include physical therapy, special education, and other supportive services.
Prognosis[edit]
The prognosis for individuals with Johnson–Munson syndrome varies depending on the severity of the symptoms. With appropriate support and treatment, many individuals with the syndrome can lead fulfilling lives.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


